Autonomix Medical, Inc (AMIX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Autonomix Medical, Inc (AMIX) is down 25.3% since the beginning of the year. At $0 per share, AMIX is trading 84.4% below its 52-week high of $3.

Autonomix Medical, Inc (AMIX) has returned -25.31% so far this year and -74.33% over the past 12 months.

Based on dividend-adjusted daily data since Jan 29, 2024, AMIX's average daily return is -0.52%, while the average monthly return is -13.39%.

Historically, 30% of months were positive and 70% were negative. The best month was Apr 2025 with a return of +33.7%, while the worst month was Nov 2024 at -65.6%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 6 months.

On a daily basis, AMIX closed higher 41% of trading days. The best single day was Jul 15, 2024 with a return of +123.3%, while the worst single day was Nov 22, 2024 at -53.6%.

Autonomix Medical, Inc has an annualized alpha of -76.67%, beta of 0.70, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since January 30, 2024.

• This stock participated in 267.22% of S&P 500 Index downside but only -188.69% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AMIX ranks 11 for risk / return — in the bottom 11% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Autonomix Medical, Inc (AMIX) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Autonomix Medical, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Autonomix Medical, Inc was 99.76%, occurring on May 19, 2026. The portfolio has not yet recovered.

The current Autonomix Medical, Inc drawdown is 99.65%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Autonomix Medical, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Autonomix Medical, Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.